RxDoctor Payments Data

Fallon Hall

Physician Assistant · Mt Sterling, KYNPI 1306412960

Payments from drug & device makers

$3,007in general payments, 2019–2025

Across 189 payments — averaging $15.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$580
  • Vanda Pharmaceuticals Inc.$349
  • Amgen$320
  • Lilly USA, LLC$269
  • Boehringer Ingelheim$195
  • Novo Nordisk$114
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$2,95898%
  • Education$492%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,007 in reported general payments places this provider in the 85th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter56$43,621
JanuviaSitagliptin Phosphate36$23,323
FarxigaDapagliflozin Propanediol40$22,243
EliquisApixaban30$22,190
OzempicSemaglutide15$19,322
JardianceEmpagliflozin24$17,634
MounjaroTirzepatide13$13,181
LinzessLinaclotide17$8,874
TrintellixVortioxetine Hydrobromide11$6,106
Albuterol Sulfate HfaAlbuterol Sulfate101$2,827
Ventolin HfaAlbuterol Sulfate39$2,148
Insulin Lispro13$1,497
Duloxetine Hcl45$846
Fluticasone Propionate107$735
Omeprazole114$734

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$102$43,62156 claims
MerckJanuvia$94$23,32336 claims
AstraZenecaFarxiga$62$22,24340 claims
PfizerEliquis$73$22,19030 claims
Novo NordiskOzempic$114$19,32215 claims
Boehringer IngelheimJardiance$195$17,63424 claims
Lilly USA, LLCMounjaro, Insulin Lispro$269$14,67826 claims
AbbVieLinzess$580$8,87417 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$31$6,10611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in Mt Sterling

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →